Tirzepatide Research Peptide

Product Overview

Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist manufactured exclusively for laboratory and scientific investigations. It is widely studied in incretin biology, metabolic signaling, peptide pharmacology, receptor biology, molecular biology, biotechnology, and experimental laboratory applications.

At BioWellLab UK, every batch of Tirzepatide is manufactured under stringent quality standards and undergoes comprehensive analytical testing to verify identity, purity, and batch-to-batch consistency before release.

Available in 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, and 60mg strengths, Tirzepatide enables researchers to select the appropriate concentration for a wide range of laboratory protocols and experimental investigations.

Researchers frequently compare Tirzepatide with Semaglutide, Retatrutide, Survodutide, and Cagrilintide in laboratory studies involving incretin signaling, receptor pharmacology, and metabolic peptide biology. Additional research peptides are available throughout the BioWellLab Shop.

This product is supplied strictly for laboratory and scientific research purposes and is not intended for human consumption or veterinary use.

Research Applications

Tirzepatide is commonly investigated in laboratory studies involving:

• GIP receptor biology
• GLP-1 receptor biology
• Dual incretin receptor signaling
• Metabolic peptide research
• Endocrine signaling pathways
• Peptide pharmacology
• Molecular biology
• Cell biology
• Biotechnology research
• Preclinical laboratory research

Product Specifications

Quality Assurance

Every BioWellLab research peptide is manufactured under rigorous quality standards and tested using validated analytical techniques, including High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography–Mass Spectrometry (LC-MS) where applicable. Each production batch is verified for purity, identity, and batch-to-batch consistency before release and is accompanied by a Certificate of Analysis (COA).

Certificates of Analysis are available upon request for supported product batches.

Storage

Store unopened vials at -20°C in a clean, dry laboratory environment. Protect from moisture, excessive heat, and direct sunlight. Avoid repeated freeze–thaw cycles after reconstitution and follow standard laboratory handling procedures.

Frequently Asked Questions

What is Tirzepatide?

Tirzepatide is a synthetic dual GIP and GLP-1 receptor agonist peptide supplied exclusively for laboratory investigations involving incretin biology, metabolic signaling, receptor pharmacology, and molecular research.

What strengths are available?

BioWellLab supplies Tirzepatide in 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 50mg, and 60mg lyophilized vials.

What purity does BioWellLab provide?

Every production batch is analytically tested to verify a purity of greater than 99% before release.

Is this product intended for human use?

No. Tirzepatide supplied by BioWellLab UK is intended strictly for laboratory research and must not be used for human consumption or veterinary applications.

Scientific Resources

Researchers seeking additional scientific information can explore the following resources:

• NCBI PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Tirzepatide
• PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Tirzepatide
• EMBL-EBI: https://www.ebi.ac.uk/
• UniProt: https://www.uniprot.org/
• IUPHAR Guide to Pharmacology: https://www.guidetopharmacology.org/

Research Use Only

Tirzepatide supplied by BioWellLab UK is intended exclusively for laboratory, analytical, and scientific research purposes. This product is not intended to diagnose, treat, cure, or prevent any disease and must not be used for human or veterinary applications. It should only be handled by qualified professionals in appropriate laboratory settings.